YOUR TRUSTED
MEDICAL TRADE PARTNER

Hong Kong Origins Investment Limited provides end-to-end cross-border trade solutions for medical devices, laboratory furniture and intelligent equipment worldwide.

GLOBAL SUPPLY CHAIN
DELIVERING EXCELLENCE

Leveraging Hong Kong's international trade hub advantages to build an efficient cross-border supply chain and value service platform for clients globally.

RELIABLE & HIGH-QUALITY
MEDICAL TRADE SERVICES
TRUSTED BY CLIENTS ACROSS THE GLOBE
WE HAVE GREAT STRENGTHS
20
+
Years Established
4
Group Companies
200
+
Brand Partners
ABOUT US

Hong Kong Origins Investment Limited is a professional cross-border trade and industrial investment enterprise rooted in Hong Kong with a global reach, focusing on international trade and industry services for medical devices and laboratory products. Leveraging Hong Kong's position as an international financial and trade hub, we have built an efficient cross-border supply chain and value service platform.

With deep expertise in international trade, we provide clients worldwide with comprehensive import/export solutions through professional supply chain management and compliance services — covering product selection, cross-border procurement, international logistics, customs clearance and local delivery. Backed by a mature global cooperation network, we have established long-term strategic partnerships with leading brands and quality manufacturers, continuously delivering high-quality, well-adapted products and services to our clients.

WHY CHOOSE ORIGINS
OUR CORE ADVANTAGES
GLOBAL EXPERTISE IN
MEDICAL DEVICE TRADE

With over a decade of professional experience in international medical device trade, we deliver comprehensive, compliant and efficient solutions that connect world-class manufacturers with healthcare and research institutions globally.

Medical Laboratory
OUR FEATURED PRODUCTS
QUALITY & COMPLIANCE
INTERNATIONAL CERTIFICATIONS
HOW WE WORK
OUR SERVICE PROCESS
01

Consultation

We start with an in-depth conversation to understand your procurement goals, budget constraints and delivery timeline.

02

Solution Design

Our specialists craft a tailored product plan with detailed quotation, lead time and supplier recommendation.

03

Procurement

We engage verified global suppliers and execute cross-border purchasing on your behalf at competitive terms.

04

Quality Control

Every batch undergoes rigorous inspection against international standards before leaving the supplier warehouse.

05

Logistics & Customs

We manage full-chain shipping, customs clearance and all import/export compliance documentation end to end.

06

Delivery & Support

Final-mile delivery, on-site installation and commissioning, with dedicated ongoing after-sales support.

TRUSTED BY LEADING ORGANIZATIONS
OUR PARTNERS & CASES
BD
Roche
Abbott
Sysmex
Beckman Coulter
Hologic
Olympus
Cervical Cancer Screening
IVD · CYTOLOGY

Cervical Cancer Screening System for Tertiary Hospital

Full BD SurePath™ LBC system deployment — covering product selection, NMPA clearance, customs import, on-site installation and clinical staff training.

HPV Genotyping Platform
IVD · MOLECULAR DIAGNOSTICS

HPV Genotyping Platform for Gynaecology Centre

End-to-end procurement of BD Viper LT™ + Onclarity™ HPV system, providing co-testing with existing LBC workflow and regulatory compliance documentation.

Vaginal Infections Detection
IVD · WOMEN'S HEALTH

BD Affirm™ VPIII Rollout for Outpatient OB/GYN Network

Coordinated multi-site deployment of BD Affirm™ VPIII vaginal infection detection systems across an outpatient network, including staff training and reagent supply chain setup.

LATEST NEWS & INDUSTRY UPDATES
BD SurePath LBC System

BY ORIGINS   MARCH 10, 2025

BD SurePath™ Gynaecological Liquid-Based Cytology System
The only FDA-certified LBC method proven to reduce unsatisfactory specimen rates, with a 64.4% higher HSIL detection rate and 100% sample preservation. READ MORE
BD Affirm VPIII Detection System

BY ORIGINS   JANUARY 15, 2025

BD Affirm™ VPIII Vaginal Infection Microbial Detection System
Industry-first DNA probe technology detects three major vaginal infections simultaneously from a single specimen in a fully automated, CDC-endorsed workflow. READ MORE
BD Viper LT HPV System

BY ORIGINS   DECEMBER 10, 2024

BD Viper LT™ System and BD Onclarity™ HPV Assay
Walk-away molecular platform targeting E6/E7 oncogenes across 14 high-risk HPV types — enabling personalised cervical cancer risk stratification from a single specimen. READ MORE
BD Affirm VPIII Clinical Study

BY ORIGINS   FEBRUARY 20, 2025

BD Affirm VPⅢ Chip Assay in Vaginal Secretion Routine Testing
A clinical study demonstrates high concordance with gold-standard methods for BV, Candida and Trichomonas detection — with improved sensitivity and objective, reproducible results. READ MORE
Non-gynaecological LBC

BY ORIGINS   AUGUST 19, 2022

Clinical Significance of Non-Gynaecological Liquid-Based Cytology
LBC technology extends beyond cervical screening — proven applications in sputum, urine and effusion cytology significantly improve lesion detection over conventional smear methods. READ MORE